![Gregory Licholai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Licholai
President at
Elpidera LLC
Profile
Founder of Immunome, Inc., Gregory P. Licholai currently is Chief Medical & Innovation Officer at ICON plc and President of Elpidera LLC. Dr. Licholai is also on the board of Sollis Therapeutics, Inc. He previously occupied the position of President & Chief Scientific Officer at Castle Creek Pharmaceuticals LLC, Vice President-Medical Affairs at Amicus Therapeutics, Inc., Director-Ventures & Business Associates at Medtronic Neurological and Director at Immunome, Inc. Gregory P. Licholai received an undergraduate degree from Boston College, a doctorate from Yale University and an MBA from Harvard University.
Gregory Licholai active positions
| Companies | Position | Start |
|---|---|---|
Elpidera LLC | President | - |
Former positions of Gregory Licholai
| Companies | Position | End |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | President | 01/02/2018 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/10/2009 |
Medtronic Neurological | Corporate Officer/Principal | 01/11/2002 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Training of Gregory Licholai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Neurological | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpidera LLC | |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
- Stock Market
- Insiders
- Gregory Licholai
